A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Carbamazepine
Test CodeAlias/See Also
Carbatrol (Carbamazepine)
Carbamazepine (Carbatrol, Tegretol)
Tegretol (Carbamazepine)
Preferred Specimen
Specimen Type: Serum
Collection Container: Serum gel
Specimen Volume: 3 mL
Minimum Volume
0.3 mL
Instructions
- In a patient on regular medication regimen, the sample should be drawn immediately prior to next carbamazepine dose.
- Centrifuge and separate cells after clot formation and within 4 hours of collection.
Transport Container
Specimen Stability
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 14 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Unlabeled, mislabeled, wrong tube type, hemolyzed, QNS, exceeds specimen stability requirements.
Methodology
Chemiluminescent microparticle immunoassay (CMIA)
Setup Schedule
Daily
Report Available
Same day
Limitations
For diagnostic purposes, results should be used in conjunction with other data: symptoms, results of other tests, clinical impressions, etc.
Potentially interfering substances include : Hemoglobin >500 mg/dL; Bilirubin >20 mg/dL; Triglycerides >3000 mg/dL; Total Protein >12 g/dL
Patients receiving mouse monoclonal antibodies for diagnosis or treatment may develop Human anti-mouse antibodies (HAMA). HAMA may cause falsely elevated or decreased values when tested with assay kits which employ mouse monoclonal antibodies. Additional information may be required for diagnosis.
Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays.
Reference Range
Clinical Significance
Carbamazepine exhibits a volume of distribution of 1.4 L/kg with an elimination half-life of 15 hours. Protein binding averages 70%.
Carbamazepine-10,11-epoxide (CBZ10-11) is an active metabolite that represents the predominant form of the drug in children. The volume of distribution of CBZ10-11 is 1.1 L/kg, and the half-life is 5-8 hours.
Aplastic anemia and agranulocytosis are rare side effects of treatment with carbamazepine; baseline hematologic data should be documented before treatment is initiated.
Toxicity associated with carbamazepine overdose occurs when the blood level is 15.0 mcg/mL or higher and is typified by irregular breathing, muscle irritability, and hyperreflexia; followed by hyporeflexia, tachycardia, hypotension, and impaired consciousness with coma in severe toxicity. The higher the blood level, the more severe the symptoms.
Performing Laboratory
Inova Laboratories
2832 Juniper Street
Fairfax, VA 22031
Last Updated: March 6, 2023
Last Review: N. Wolford, March 6, 2023